Literature DB >> 19834401

Dural augmentation: part I-evaluation of collagen matrix allografts for dural defect after craniotomy.

Zachary N Litvack1, G Alexander West, Johnny B Delashaw, Kim J Burchiel, Valerie C Anderson.   

Abstract

OBJECTIVE: Primary closure of the dura remains difficult in many neurosurgical cases. One option for dural grafting is the collagen sponge, which is available in multiple forms, namely, monolayer collagen and bilayer collagen. Our primary goal was to assess differences in the incidence of postoperative cerebrospinal fluid (CSF) leak, including fistula and pseudomeningocele, and postoperative infection between monolayer collagen and bilayer collagen grafts.
METHODS: A single-center retrospective analysis of 475 consecutive neurosurgical procedures was performed. Primary endpoints were CSF leak and infection, adjusting for the impact of additional nonautologous materials. Multivariate regression analysis was used to identify predictors of postoperative CSF leak and infection.
RESULTS: The overall frequency of postoperative CSF leak was 6.7%. There was no significant difference in the incidence of CSF leak based on the type of collagen sponge (monolayer versus bilayer) used (5.5% versus 7.5%, respectively; P = 0.38). The overall frequency of postoperative infection was 4.2%. There was no significant difference in the incidence of infection between groups (4.9% versus 3.8%; P = 0.54). Bilayer sponges were associated with a significantly lower incidence of CSF leak than monolayer sponges (odds ratio, 0.09; 95% confidence interval, 0.01-0.73).
CONCLUSION: Bilayer collagen sponges are associated with a reduction in postoperative CSF leak, notably in posterior fossa surgery. The need for additional non-native materials is predictive of postoperative CSF leak, along with location and type of procedure. Intrinsic patient characteristics (e.g., age, diabetes, smoking) do not seem to affect the efficacy of collagen sponge dural grafts.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19834401     DOI: 10.1227/01.NEU.0000356970.22315.BC

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  7 in total

1.  The use of abdominal free fat for volumetric augmentation and primary dural closure in supratentorial skull base surgery: managing the stigma of a temporal defect.

Authors:  Paul D Ackerman; Ronald Hammers; Tarik Ibrahim; T C Origitano
Journal:  J Neurol Surg B Skull Base       Date:  2012-04

Review 2.  The incidence of postoperative cerebrospinal fluid leakage after elective cranial surgery: a systematic review.

Authors:  Birgit Coucke; Laura Van Gerven; Steven De Vleeschouwer; Frank Van Calenbergh; Johannes van Loon; Tom Theys
Journal:  Neurosurg Rev       Date:  2021-09-09       Impact factor: 3.042

3.  Pseudomeningocele formation following chiari decompression: 19-year retrospective review of predisposing and prognostic factors.

Authors:  R Menger; D E Connor; M Hefner; G Caldito; A Nanda
Journal:  Surg Neurol Int       Date:  2015-05-07

4.  The need in dural graft suturing in Chiari I malformation decompression: A prospective, single-blind, randomized trial comparing sutured and sutureless duraplasty materials.

Authors:  Leena E Williams; Prasad S Vannemreddy; Karriem S Watson; Konstantin V Slavin
Journal:  Surg Neurol Int       Date:  2013-02-27

5.  Fibrin sealant augmentation with autologous pericranium for duraplasty after suboccipital decompression in Chiari 1 patients: A case series.

Authors:  Fred C Lam; Anirudh Penumaka; Clark C Chen; Edwin G Fischer; Ekkehard M Kasper
Journal:  Surg Neurol Int       Date:  2013-01-18

6.  Evaluation of Non-Watertight Dural Reconstruction with Collagen Matrix Onlay Graft in Posterior Fossa Surgery.

Authors:  Varun R Kshettry; Bjorn Lobo; Joshua Lim; Burak Sade; Soichi Oya; Joung H Lee
Journal:  J Korean Neurosurg Soc       Date:  2016-01-20

7.  Safety and Efficacy of a Novel, Self-Adhering Dural Substitute in a Canine Supratentorial Durotomy Model.

Authors:  Kevin M Lewis; Jenifer Sweet; Scott T Wilson; Serge Rousselle; Heinz Gulle; Bernhard Baumgartner
Journal:  Neurosurgery       Date:  2018-03-01       Impact factor: 4.654

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.